Search the Newsreel

CLAR Maintained by Roth Capital -- Price Target Raised to $3.75

Roth Capital has maintained a Neutral rating on Clarus Corporation (CLAR) but raised its price target to $3.75, an increase of 29.31%. Despite a slight undervaluation according to GF Value™ at $3.86 versus its current price of $3.82, the company's unprofitability and negative cash …

Kimberly-Clark Corporation (KMB) latest stock news and headlines

This Yahoo Finance page provides a compilation of recent news and headlines concerning Kimberly-Clark Corporation (KMB). It highlights the company's Q2 2026 earnings, including a focus on China risk and a lowered 2026 outlook, as well as announcements regarding a cash dividend and an …

Clarivate PLC (16A.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst ratings and price targets for Clarivate PLC (16A.MU). It lists recent "Upgrades & Downgrades" showing various firms maintaining their ratings, including Citigroup, Goldman Sachs, Stifel, and Barclays, with the latest update on July 30, 2026. The stock's current price is …

Clarus Securities Weighs in on TSE:PIF FY2026 Earnings

Claros Mortgage Trust president and CFO Mike McGillis buys $42,730 in stock

Claros Mortgage Trust President and CFO Mike McGillis recently purchased 25,000 shares of the company's common stock for $42,730, bringing his total direct holdings to 749,000 shares. This insider buying occurs as the stock trades near its 52-week low, appearing undervalued according to InvestingPro …

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Brokerages

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) has received an average "Buy" rating from brokerages, with an average 12-month price target of $11.50. Institutional investors hold a significant portion of the stock, and several firms increased their positions recently. The company also surpassed its latest quarterly earnings …

Top Executive Makes Bold Insider Move at Claros Mortgage Trust

Mike Mcgillis Acquires 25,000 Shares of Claros Mortgage Trust (NYSE:CMTG) Stock

Claros Mortgage Trust (NYSE:CMTG) CFO Mike Mcgillis recently purchased 25,000 shares of the company's stock for $1.71 per share, increasing his direct ownership to 749,000 shares. This insider buying occurred after CMTG shares fell 8.2% to $1.78, nearing a 52-week low, following a reported …

Kenneth Cornick Acquires 650,000 Shares of Clarivate (NYSE:CLVT) Stock

Clarivate director Kenneth Cornick recently acquired 650,000 shares of NYSE:CLVT stock for approximately $1.21 million, significantly increasing his direct ownership by 59.09% to 1.75 million shares. Despite Clarivate's shares rising 4.4% to $1.90, they remain near their one-year low, and analysts maintain a cautious …

Clarivate (NYSE:CLVT) Director Kenneth Cornick Buys 250,000 Shares of Stock

Clarivate (NYSE:CLVT) Director Kenneth Cornick purchased 250,000 shares of the company's stock on August 7th, investing $462,500 at an average price of $1.85 per share. This transaction increased his direct ownership to 2 million shares, a 14.29% increase. Despite the insider buying, analyst sentiment …

KIMBERLY-CLARK AKTIE: AI-Analysen, Prognose & Kursziel

What's Going On With Aclara Resources Inc Stock Monday?

Kimberly-Clark plans major shakeup after Kenvue deal

Kimberly-Clark is accelerating its acquisition of Kenvue, planning to consolidate systems and operations to achieve $1.9 billion in cost synergies and expand its health and wellness portfolio. The $48.7 billion deal, expected to close by the end of 2026, will create a $32 billion …

Claritev Analysts Raise Their Forecasts Following Q2 Earnings

Kimberly-Clark completa 30 anos no Brasil com o maior índice de engajamento entre todas as operações globais

Clarity Pharmaceuticals (ASX:CU6) Rises As SECuRE Trial Delivers More Responses

Canaccord raises Claritev stock price target to $43 on bookings

Kimberly-Clark gears up for major Kenvue overhaul

Kimberly-Clark is actively preparing for its acquisition of Kenvue, which is expected to close by the end of 2026. This merger will create a $32 billion global health and wellness company, with Kimberly-Clark anticipating approximately $1.9 billion in cost synergies and $500 million in …

Matrix Trust Co Invests $2.07 Million in Kimberly-Clark Corporation $KMB

Matrix Trust Co. recently acquired a new stake of 18,888 shares, valued at $2.07 million, in Kimberly-Clark Corporation (NASDAQ:KMB) during the second quarter. Despite missing analyst estimates for quarterly earnings and revenue, the company reported a slight year-over-year revenue increase and declared a quarterly …

13,509 Shares in Kimberly-Clark Corporation $KMB Acquired by Fluent Financial LLC

Fluent Financial LLC acquired 13,509 shares of Kimberly-Clark Corporation (NASDAQ:KMB) in the second quarter, valued at approximately $1.48 million. This move is part of broader institutional interest, with several other hedge funds also adjusting their positions in KMB. Despite Kimberly-Clark reporting quarterly EPS below …

Kimberly-Clark Corporation (NYSE:KMB): Can Operational Strength Drive Growth?

This article from Kalkine Media discusses Kimberly-Clark Corporation (NYSE:KMB) and explores whether its operational strength can drive future growth. It touches upon factors like demand conditions, competitive pressure, regulation, and operating execution, particularly focusing on the company's positioning for broader health and wellness trends …

Kimberly-Clark Corp (KMB) Stock News Today

This article provides recent stock news for Kimberly-Clark Corp (KMB), including its current stock price, market cap, and P/E TTM. It also lists several news items related to Procter & Gamble Co (PG) and Unilever PLC (UL), highlighting their stock movements on specific dates. …

Clarus Corporation Just Reported A Surprise Profit And Analysts Updated Their Estimates

Enterprise value to EBIT forward of Clarivate Plc – NYSE:CLVT

The article focuses on the enterprise value to EBIT forward for Clarivate Plc (NYSE: CLVT). It presents financial data within the TradingView platform context, highlighting the company's stock information and financial metrics. The primary content available is a data point for this specific financial …

Claritev (CTEV) Stock Jumps On Margin Strength Despite Ongoing Losses

Kimberly-Clark Corporation (KMB) Stock Forecasts

This article provides an analyst report from Morningstar on Kimberly-Clark Corporation (KMB), a leading manufacturer in the tissue and hygiene sector. The report, authored by Erin Lash, discusses the company's financial standing and brand portfolio, which includes popular names like Huggies, Kotex, and Kleenex. …

Aclaris Therapeutics, Inc. (ACRS) stock price, news, quote and history

This page provides a comprehensive overview of Aclaris Therapeutics, Inc. (ACRS) stock, including its current price, historical data, key statistics, and company profile. Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for immuno-inflammatory diseases, with several drug candidates in various trial …

Projeções de Resultados: Kimberly-Clark Corp (KMB) — LPA e Crescimento de Receita

Claritev Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:CTEV) 2026-08-08

Claritev Q2 Earnings Call Highlights

Key Points Interested in Claritev? Here are five stocks we like better. Strong second-quarter performance: Revenue rose 6.6% year over year to $257.5 million, while adjusted EBITDA reached $155.8 million and operating cash flow increased 51% to $93 million. Claims Intelligence, particularly No Surprises …

Clarus Corp (CLAR) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Clarus Corp (CLAR), noting its current earnings forecast score of 6.50, ranking 21st in the Leisure Products industry. Analysts have set an average price target of $3.75 for CLAR, with a "Hold" rating based on 4 analysts. …

Kimberly-Clark Picks Arizona for $100M Pilot Project

Kimberly-Clark is investing $100 million in a new 50,000-square-foot pilot facility in Yuma, Arizona, creating 50 full-time jobs. This plant will extract natural fibers from hesperaloe, a low-water, rapidly renewable plant native to the Southwest, for potential use in future hygiene products. The facility …

Kimberly-Clark Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KMB) 2026-08-07

Kimberly-Clark Corp (KMB) will host an earnings conference call on August 4, 2026, at 8:00 AM ET to discuss its Q2 26 financial results. A live webcast of the call will be accessible via the company's investor relations website.

Aclaris Therapeutics (ACRS) Stock Drifts Lower As Losses Deepen On Thin Revenue

Aclaris Updates At-The-Market Equity Sales Agreement

Claritev signals $1.0B-$1.02B 2026 revenue outlook as bookings target stays at $100M

Earnings Call Insights: Claritev Corporation (CTEV) Q2 2026 MANAGEMENT VIEW * "We're pleased to announce another strong quarter for Claritev and continued progress on our turnaround journey." (CEO, President & Chairman Travis Dalton) "At our Investor Day in March, we introduced 2026 as the …